Advertisement

Researchers at MIT and Brigham and Women’s Hospital have found a way to bring precision measurements to combination drug therapy in treating prostate cancer.

The researchers developed a nanoparticle capable of “drug-polymer blending” – delivering precise dosages of one or two drugs. While the research focused on drug delivery to prostate cancer cells, the study could apply to other types of cancers and other types of drugs.

SOURCE

Advertisement
Advertisement